Amplitude Therapeutics
PrivateLast Round
Grant
Nov 1, 2024
Total Funding Raised
$3.77M
Company Overview
Amplitude Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Grant round in November 2024.
Amplitude Therapeutics is a biotechnology company that develops ribonucleic acid medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amplitude Therapeutics Comparables
Compare Amplitude Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Replicate Bioscience | 83% | |
| Ziphius Vaccines | 80% | |
| Eli Lilly and Company | 77% |
For institutional investors. Book with your work email.
Amplitude Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2024 | ||||
| Grant | Aug 20, 2024 | ||||
| Grant | Mar 7, 2024 | ||||
| Seed | Mar 7, 2024 |
For institutional investors. Book with your work email.
Amplitude Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newpath Partners | Seed |
| CEPI | Grant |
| Administration for Strategic Preparedness and Response | Grant |
| ARCH Venture Partners | Seed |
| Bill & Melinda Gates Foundation | Grant |
| Alta Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2024
Secured $2.04M in grant funding.
- Aug 20, 2024
$733K grant round completed.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 23, 2026
In Aug '26, Amplitude collaborates with Lilly to discover and develop trans-amplifying RNA vaccine candidates for infectious diseases, leading early platform optimization before Lilly-led development.
- is_developingAug 21, 2026
On Aug 21st '26, Amplitude enters a strategic research collaboration and licensing agreement with Eli Lilly to discover and develop trans-amplifying RNA vaccine candidates for infectious diseases.
- partners_withAug 21, 2026
Amplitude partners with Lilly Group to develop trans-amplifying RNA vaccines for infectious diseases, announced on Aug 19th '26.
For institutional investors. Book with your work email.
Amplitude Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amplitude Therapeutics's valuation, stock price, and market status.
Is Amplitude Therapeutics a public or private company?
Amplitude Therapeutics is a private company.
What is the current stock price of Amplitude Therapeutics?
Amplitude Therapeutics is a private company, so its shares have no public market price. Caplight tracks Amplitude Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amplitude Therapeutics worth (valuation)?
Valuation information for Amplitude Therapeutics is not publicly available.
Can I buy Amplitude Therapeutics stock?
Amplitude Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amplitude Therapeutics's last funding round?
Amplitude Therapeutics's most recent funding round was Grant on November 1, 2024.
Who are the main investors in Amplitude Therapeutics?
Key investors in Amplitude Therapeutics include ARCH Venture Partners, Alta Partners.
Will Amplitude Therapeutics IPO soon?
No public IPO plans have been announced for Amplitude Therapeutics.
How can I track Amplitude Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Amplitude Therapeutics's shares on secondary markets.